Confirmed Disability Improvement in Secondary Progressive Multiple Sclerosis patients treated with Siponimod evaluated through several clinical measures for disability evaluation.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma